Loomis, Sayles & Company’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-168
| Closed | -$37K | – | 1057 |
|
|
2023
Q1 | $37K | Buy |
168
+14
| +9% | +$3.08K | ﹤0.01% | 668 |
|
|
2022
Q4 | $32K | Buy |
+154
| New | +$32K | ﹤0.01% | 684 |
|
|
2021
Q4 | – | Sell |
-540
| Closed | -$142K | – | 879 |
|
|
2021
Q3 | $142K | Hold |
540
| – | – | ﹤0.01% | 551 |
|
|
2021
Q2 | $133K | Sell |
540
-186
| -26% | -$45.8K | ﹤0.01% | 547 |
|
|
2021
Q1 | $141K | Hold |
726
| – | – | ﹤0.01% | 529 |
|
|
2020
Q4 | $154K | Hold |
726
| – | – | ﹤0.01% | 509 |
|
|
2020
Q3 | $124K | Sell |
726
-79
| -10% | -$13.5K | ﹤0.01% | 530 |
|
|
2020
Q2 | $154K | Buy |
805
+9
| +1% | +$1.72K | ﹤0.01% | 506 |
|
|
2020
Q1 | $117K | Sell |
796
-401
| -34% | -$58.9K | ﹤0.01% | 528 |
|
|
2019
Q4 | $186K | Buy |
1,197
+727
| +155% | +$113K | ﹤0.01% | 533 |
|
|
2019
Q3 | $64K | Buy |
+470
| New | +$64K | ﹤0.01% | 594 |
|
|
2016
Q1 | – | Sell |
-1,199
| Closed | -$64K | – | 1121 |
|
|
2015
Q4 | $64K | Sell |
1,199
-830
| -41% | -$44.3K | ﹤0.01% | 729 |
|
|
2015
Q3 | $103K | Buy |
+2,029
| New | +$103K | ﹤0.01% | 741 |
|